Trials / Conditions / Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
4 registered clinical trials studyying Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resi NCT07202494 | Assistance Publique Hopitaux De Marseille | — |
| Recruiting | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participan NCT05271409 | Hoffmann-La Roche | Phase 3 |
| Recruiting | Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the N NCT04561557 | Tongji Hospital | EARLY_Phase 1 |
| Recruiting | Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) NCT05017142 | University of Bern | — |